LP
KDNY

LMR Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

LMR Partners’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-164,578
Closed -$6.32M – 941
2023
Q2 		$6.32M Buy
+164,578
New +$6.32M 0.07% 156